Multifaceted Immunomodulatory Nanocomplexes Target Neutrophilic‐ROS Inflammation in Acute Lung Injury (Adv. Sci. 8/2025)

Immunomodulatory Nanocomplexes This study develops immunomodulatory nanocomplexes for treating acute lung injury. By disrupting ROS-neutrophilic inflammation, it reduces oxidative stress, pro-inflammatory cell infiltration, and immune cell activation, effectively alleviating inflammatory damage in ALI mice. More details can be found in article number 2411823 by Ya-Xuan Zhu, Han Lin, Bin He, and co-workers.